CAJ | 학술논문

目的:观察人工肝支持系统治疗乙型重型肝炎的疗效.方法:选取乙型重型肝炎患者76例,治疗组33例患者进行了41次血浆置换,对照组43不用人工肝支持系统进行治疗.结果:治疗组在临床症状、肝功能、PT、FFA等指标的改善明显优于对照组(P<0.01);治疗组生存率与对照组比较,差异有显著性(P<0.01).结论:药物联合人工肝支持系统治疗乙型重型肝炎,给肝功能恢复与肝脏的再生创造良好的内环境,同时还降低病死率,提高生存率.
목적:관찰인공간지지계통치료을형중형간염적료효.방법:선취을형중형간염환자76례,치료조33례환자진행료41차혈장치환,대조조43불용인공간지지계통진행치료.결과:치료조재림상증상、간공능、PT、FFA등지표적개선명현우우대조조(P<0.01);치료조생존솔여대조조비교,차이유현저성(P<0.01).결론:약물연합인공간지지계통치료을형중형간염,급간공능회복여간장적재생창조량호적내배경,동시환강저병사솔,제고생존솔.
Objective:To explore the effect of artificial liver support system (ALSS)in treatment of severe hepatitis. Methods:76 patients with severe hepatitis were selected.33 patients in the treatment group were received ALSS for 41 times,and 43 patients in the control group were no received ALSS.Results:Liver function,PT,PTA and other indicators of the treatment group were improved better than those of the control group (P<0.01);the survival rate of the treatment group had significant statistical significance compared with the control group (P<0.01).Conclusion:Drug combined ALSS for treating severe hepatitis creates a good environment of liver function recov-ery,liver regeneration and reduces the mortality improvs survival rates.